Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D Cannon

Showing results (611-620 of 837) with videos related to

Pageof 84
Sort By:
Translational Psychiatry|September 12, 2017
Neuregulin signaling pathway in smoking behaviorR Gupta, B Qaiser, L He, et al.
Psychological Medicine|August 29, 2023
Improving prediction of psychosis in youth at clinical high-risk: pre-baseline symptom duration and cortical thinning as moderators of the NAPLS2 risk calculatorMichelle A Worthington, Meghan A Collins, Jean Addington, et al.
Frontiers in Psychiatry|January 30, 2025
Predicting conversion to psychosis using machine learning: response to CannonJason Smucny, Tyrone D Cannon, Carrie E Bearden, et al.
Psychiatry Research. Neuroimaging|June 13, 2016
Relation between cannabis use and subcortical volumes in people at clinical high risk of psychosisLisa Buchy, Daniel H Mathalon, Tyrone D Cannon, et al.
The American Journal of Psychiatry|September 12, 2019
Characterizing Covariant Trajectories of Individuals at Clinical High Risk for Psychosis Across Symptomatic and Functional DomainsDana M Allswede, Jean Addington, Carrie E Bearden, et al.
Biological Psychiatry. Cognitive Neuroscience and Neuroimaging|April 30, 2021
Life Event Stress and Reduced Cortical Thickness in Youth at Clinical High Risk for Psychosis and Healthy Control SubjectsKatrina Aberizk, Meghan A Collins, Jean Addington, et al.
Schizophrenia Research|July 12, 2014
Current status specifiers for patients at clinical high risk for psychosisScott W Woods, Barbara C Walsh, Jean Addington, et al.
Proceedings of the National Academy of Sciences of the United States of America|February 28, 2002
Cortex mapping reveals regionally specific patterns of genetic and disease-specific gray-matter deficits in twins discordant for schizophreniaTyrone D Cannon, Paul M Thompson, Theo G M van Erp, et al.
Schizophrenia Research|April 18, 2025
Cultural variables influence performance on the MATRICS Consensus Cognitive Battery among people at clinical high risk for psychosisRyan M Guest, Katrina Aberizk, Jean Addington, et al.
Schizophrenia Bulletin|February 20, 2014
The relationship of neurocognition and negative symptoms to social and role functioning over time in individuals at clinical high risk in the first phase of the North American Prodrome Longitudinal StudyEric C Meyer, Ricardo E Carrión, Barbara A Cornblatt, et al.
Pageof 84

Showing results (611-620 of 837) with videos related to

Sort By:
Pageof 84
Translational Psychiatry|September 12, 2017
Neuregulin signaling pathway in smoking behaviorR Gupta, B Qaiser, L He, et al.
Psychological Medicine|August 29, 2023
Improving prediction of psychosis in youth at clinical high-risk: pre-baseline symptom duration and cortical thinning as moderators of the NAPLS2 risk calculatorMichelle A Worthington, Meghan A Collins, Jean Addington, et al.
Frontiers in Psychiatry|January 30, 2025
Predicting conversion to psychosis using machine learning: response to CannonJason Smucny, Tyrone D Cannon, Carrie E Bearden, et al.
Psychiatry Research. Neuroimaging|June 13, 2016
Relation between cannabis use and subcortical volumes in people at clinical high risk of psychosisLisa Buchy, Daniel H Mathalon, Tyrone D Cannon, et al.
The American Journal of Psychiatry|September 12, 2019
Characterizing Covariant Trajectories of Individuals at Clinical High Risk for Psychosis Across Symptomatic and Functional DomainsDana M Allswede, Jean Addington, Carrie E Bearden, et al.
Biological Psychiatry. Cognitive Neuroscience and Neuroimaging|April 30, 2021
Life Event Stress and Reduced Cortical Thickness in Youth at Clinical High Risk for Psychosis and Healthy Control SubjectsKatrina Aberizk, Meghan A Collins, Jean Addington, et al.
Schizophrenia Research|July 12, 2014
Current status specifiers for patients at clinical high risk for psychosisScott W Woods, Barbara C Walsh, Jean Addington, et al.
Proceedings of the National Academy of Sciences of the United States of America|February 28, 2002
Cortex mapping reveals regionally specific patterns of genetic and disease-specific gray-matter deficits in twins discordant for schizophreniaTyrone D Cannon, Paul M Thompson, Theo G M van Erp, et al.
Schizophrenia Research|April 18, 2025
Cultural variables influence performance on the MATRICS Consensus Cognitive Battery among people at clinical high risk for psychosisRyan M Guest, Katrina Aberizk, Jean Addington, et al.
Schizophrenia Bulletin|February 20, 2014
The relationship of neurocognition and negative symptoms to social and role functioning over time in individuals at clinical high risk in the first phase of the North American Prodrome Longitudinal StudyEric C Meyer, Ricardo E Carrión, Barbara A Cornblatt, et al.
Pageof 84